CVS suspends sales of Zantac brand due to contaminant fears.
CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.that some of the pills contained small amounts N-nitrosodimethylamine , which has also been found in some widely used blood pressure medicines, leading to shortages of those drugs.
CVS said the move to suspend sales of the over-the-counter heartburn drug was taken out of caution while the FDA continues to review if low levels of NDMA in ranitidine — the active ingredient in Zantac — poses a health risk to patients. "Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time,"
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Consulte Mais informação »
CVS pulls Zantac and similar heartburn drugs because of cancer worriesCVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
Consulte Mais informação »
CVS suspends sales of Zantac brand and generic heartburn drug during safety reviewCVS Health Corp said on Saturday it will discontinue sales the popular Zantac he...
Consulte Mais informação »